As sponsors advanced more niche and personalized modalities, manufacturers were pushed to adopt holistic approaches to safety ...

For those monitoring innovation pipelines, patent intelligence is becoming a leading indicator of competitive positioning.

ViiV Healthcare has reported several successful HIV trials at CROI 2026, including its investigational candidates lotivibart, VH184 and VH499.

Following the launch of its Wegovy (semaglutide) pill at the beginning of the year, Novo Nordisk is committing as much as ...

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system (CNS) disorders, ...

After its next-generation obesity asset CagriSema lost a head-to-head matchup with Eli Lilly’s Zepbound, Novo Nordisk is ...

The use of acidic MPAs (pH 2–4) is the default in pharmaceutical testing because they suppress silanol ionization (from Si-OH to Si-O -) and improve peak shape for basic drugs. However, highly ...

Biocon Ltd has received US FDA approval for its complex formulation Liraglutide Injection 18 mg/3 mL (6 mg/mL) single-patient-use prefilled pens (gSaxenda). The drug-device combination is indicated ...

The collaboration will leverage Eris’s commercial presence in the diabetes segment and Natco’s manufacturing and regulatory ...

Vivtex is set to receive research funding, upfront payments, milestone payments up to $2.1bn, and tiered royalties.

The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions ...

Aurobindo Pharma’s subsidiary Eugia Pharma Unit-I in Telangana was inspected by the US FDA from February 16 to 27, 2026, ...